Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on May 1, 2009

Papers In Press, published online ahead of print January 9, 2009
J. Lipid Res., doi:10.1194/jlr.M800402-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M800402-JLR200v1
50/5/832    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scazzocchio, B.
Right arrow Articles by Masella, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scazzocchio, B.
Right arrow Articles by Masella, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on July 30, 2008
Revised on December 30, 2008
Accepted on January 8, 2009

Oxidized low-density lipoproteins impair adipocyte response to insulin by activating serine/threonine kinases

Beatrice Scazzocchio, Rosaria Varì, Massimo D'Archivio, Carmela Santangelo, Carmelina Filesi, Claudio Giovannini, and Roberta Masella

Veterinary Public Health and Food Safety, Istituto Superiore di Sanità, Roma

Corresponding Author: masellar{at}iss.it

Oxidized LDL (oxLDL) increase in patients affected by type-2 diabetes, obesity and metabolic syndrome. Likewise, insulin resistance -an impaired responsiveness of target tissues to insulin- is associated with those pathological conditions. To investigate a possible causal relationship between oxLDL and the onset of insulin resistance, we evaluated the response to insulin of 3T3-L1 adipocytes treated with oxLDL. We observed that oxLDL inhibited glucose uptake (-40%) through reduced glucose transporter 4 (GLUT4) recruitment to the plasma membrane (-70%), without affecting GLUT4 gene expression. These findings were associated to the impairment of insulin signaling. Specifically, in oxLDL-treated cells insulin receptor substrate-1 (IRS-1) was highly degraded likely because of the enhanced Ser307phosphorylation. This process was largely mediated by the activation of the inhibitor of B-kinase beta (IKKbeta ) and the c-Jun NH2-terminal kinase (JNK). Moreover, the activation of IKKbeta positively regulated the nuclear content of NF-B, by inactivating the inhibitor of NF-B (IBa). The activated NF-B further impaired per se GLUT4 functionality. Specific inhibitors of IKKbeta , JNK and NF-B restored insulin sensitivity in adipocytes treated with oxLDL. These data provide the first evidence that oxLDL, by activating serine/threonine kinases, impaired adipocyte response to insulin affecting pathways involved in the recruitment of GLUT4 to plasma membranes. This suggests that oxLDL might participate in the development of insulin resistance


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement